NEW YORK, Dec. 5, 2017 /PRNewswire/ -- Growth in high viscosity drugs is being driven by advances in biotechnology and host-vector engineering â€" advances that have led to a steady stream of biologics for a number of ailments and conditions. These powerful drugs come with a high cost-per-dose and the risk of significant side effects â€" factors that place an elevated emphasis on administration efficiency, safety and reliability.
Read the full report: https://www.reportlinker.com/p05232367Many drugs in this class are characterized by physical properties and sensitivities that challenge the drug commercialization ecosystem. For example, monoclonal antibodies, perhaps the most significant category in terms of therapeutic and commercial importance, typically possess viscosities that are well above the normal limits of subcutaneous injection devices and techniques.
Without a technical solution, these high viscosity drugs are formulated and supplied for infusion, a trend that threatens to put additional pressure on patient logistics and healthcare economics. Drug developers and device designers are increasingly working in collaboration to insure the commercial success of handheld devices forÂ high viscosity injectables.
What You Will Learnâ€¢ What are the markets for therapeutic drugs with viscosities that cannot be delivered using standard self-injection devices and techniques?â€¢ What are the technologies and devices that are aimed at positioning high viscosity drugs for subcutaneous injection?â€¢ What are the design factors, material selection issues, formulation factors, and device capabilities and limitations of handheld devices that address the limitations of Â Â high viscosity drugs?â€¢ Who are the high viscosity injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?â€¢ What are the key therapeutic sectors for high viscosity injectables?â€¢ What does the market for high viscosity injectables look like today? What will it be in 2024?â€¢ What is the impact of economic, technology, and regulatory factors on high viscosity drugs that can be administered via handheld devices?
Read the full report: https://www.reportlinker.com/p05232367 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001